Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

Published:2024-06 Issue:6 Volume:9 Page:1919-1922
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

van Schaik Mieke,de Vries Aiko P.J.,Bemelman Frederike J.,Rabelink Ton J.,Trouw Leendert A.,van Kooten Cees,Teng Yoe Kie Onno

Funder

University of Iowa

Publisher

Elsevier BV

Reference9 articles.

1. Dense deposit disease;Smith;Mol Immunol,2011

2. C3 glomerulopathy;Koopman;Nephrol Dial Transplant,2021

3. Recurrence of dense deposits in transplanted kidneys: I. Sequential survey of the lesions;Droz;Kidney Int,1979

4. C3 glomerulopathy - understanding a rare complement-driven renal disease;Smith;Nat Rev Nephrol,2019

5. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome;Iatropoulos;Mol Immunol,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases;Scientific Reports;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP